Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CRISPR Therapeutics (CRSP)

CRISPR Therapeutics AG
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRSP
DateTimeSourceHeadlineSymbolCompany
03/06/202413:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
31/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
31/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
31/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
30/05/202421:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
29/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
29/05/202413:00GlobeNewswire Inc.CRISPR Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:CRSPCRISPR Therapeutics AG
24/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
23/05/202421:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
23/05/202413:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
23/05/202413:00GlobeNewswire Inc.CRISPR Therapeutics Strengthens Executive Leadership Team with Key AppointmentsNASDAQ:CRSPCRISPR Therapeutics AG
09/05/202413:30GlobeNewswire Inc.CRISPR Therapeutics to Present at the Bank of America Securities Health Care ConferenceNASDAQ:CRSPCRISPR Therapeutics AG
08/05/202421:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRSPCRISPR Therapeutics AG
08/05/202421:00GlobeNewswire Inc.CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:CRSPCRISPR Therapeutics AG
08/05/202412:00GlobeNewswire Inc.CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing ApproachNASDAQ:CRSPCRISPR Therapeutics AG
22/04/202421:30GlobeNewswire Inc.CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual MeetingNASDAQ:CRSPCRISPR Therapeutics AG
03/04/202413:00GlobeNewswire Inc.CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare ConferenceNASDAQ:CRSPCRISPR Therapeutics AG
01/04/202413:00GlobeNewswire Inc.CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual MeetingNASDAQ:CRSPCRISPR Therapeutics AG
13/03/202412:30GlobeNewswire Inc.CRISPR Therapeutics Proposes New Appointment to the Board of DirectorsNASDAQ:CRSPCRISPR Therapeutics AG
21/02/202422:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
21/02/202422:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
21/02/202412:50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRSPCRISPR Therapeutics AG
21/02/202412:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
21/02/202412:30GlobeNewswire Inc.CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:CRSPCRISPR Therapeutics AG
16/02/202422:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
15/02/202421:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
15/02/202413:30GlobeNewswire Inc.CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership SummitNASDAQ:CRSPCRISPR Therapeutics AG
13/02/202413:44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRSPCRISPR Therapeutics AG
13/02/202413:30GlobeNewswire Inc.CRISPR Therapeutics Announces $280 Million Registered Direct OfferingNASDAQ:CRSPCRISPR Therapeutics AG
13/02/202411:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
 Showing the most relevant articles for your search:NASDAQ:CRSP

Your Recent History

Delayed Upgrade Clock